BIOPSY-5 🧪 bio/acc Incentives Program

Strategic Purpose: Provide clear milestones and standardized metrics for bioDAOs with incentives to achieve them and use this data to help BIO optimize our bioDAO incubation and support systems.

Target Metric: Value of non-native assets in BIO reserves and bioDAO treasuries

TLDR

• 4% of BIO supply (132,800,000 BIO) is allocated to bio/acc incentives
• This initial bio/acc 1st Generation will end on January 17th, 2025 (6 months)
• Create a bio/acc cell (cell = elected BIO contributors with delegated access and authority) to oversee the evaluation and distribution of rewards
• Milestones and qualifications for bio/acc rewards are subject to change by bio/acc cell
• Non-BIO DeSci orgs can qualify for bio/acc rewards
• A portion of the bio/acc rewards will be allocated retroactively to existing DeSci orgs. Retroactive rewards are fully vested. Future bio/acc rewards are vested linearly for 24 months

Why incentivize bio/acc?

The goal of launching the BIO token is to leverage crypto-incentives to accelerate the growth of our community, their innovative products, and our brand as a leader in the biotech industry is a key part of this strategy. Nurturing the growth of biotech communities is imperative for the sustained success of BIO.

Biotech communities are navigating uncertain waters, facing a myriad of challenges from R&D to regulatory hurdles to financial constraints. By providing incentives tied to milestones we will accelerate development and ensure alignment between bioDAO<>BIO and bioDAO<>bioDAO through their shared ownership in BIO. These milestones become clear markers of success to guide bioDAOs and their communities.

The selected metrics optimize for increasing the amount and value of onchain IP, which we believe is a fundamental value driver for bioDAOs. We use data rooms tracking progress to bring transparency to bio/acc rewards and generational progression to iterate on target milestones, payout amounts, and incentive structure over time.

bioDAO bio/acc rewards

Name	Metric	Reward
Translational Effectiveness (Tier 1)	Launch a product with >$1M revenue	30,000,000
Translational Effectiveness (Tier 2)	Launch a product with >$10M revenue	125,000,000
Launch IPT (Tier 1)	IPT >$5M FDV for 1 month	5,000,000
Launch IPT (Tier 2)	IPT >$50M FDV for 1 month	30,000,000
Launch IPT (Tier 3)	IPT >$250M FDV for 1 month	125,000,000
Conduct Decentralized Clinical Trial	n ≥ 1,000 across 3 continents	5,000,000
Token auction on BIO Launchpad	>$1M raised	3,000,000
Trading Day (Tier 1)	>$5M global daily volume OR >$1M daily volume on a CEX launch	3,000,000
Trading Day (Tier 2)	>$25M global daily volume OR >$5M daily volume on a CEX launch	10,000,000
Community Size	>1,000 addresses staked for products/services/governance	3,000,000

bioHacker bio/acc rewards

Name	Metric	Reward
Use bio/acc products	E.g. Follistatin, Vitarna, cybernetic implants	100,000
Contribute to clinical trials or self-reporting	E.g. OPSY, decentralized trials	5,000
Buy bio products	$ spent in offline/online stores	2,000

bioDAO Retroactive Rewards

Criteria	$BIO reward	VITA	NEURON
Token auction on BIO Launchpad	3,000,000	1	1
Launch IPT (Tier 1)	15,000,000	1	0
Trading Day (Tier 1)	3,000,000	1	0
Total		21,000,000	3,000,000

bio/acc Cell Evaluation & Distribution

This proposal creates a bio/acc cell which is responsible for evaluating the eligibility for DeSci DAOs to receive rewards and for distributing them. A BIO cell is an autonomous unit (ex. Multisig, subDAO) with delegated access and authority to modules in the bioconomy (ex. $BIO minting, liquidity management).

The bio/acc cell is a 2/3 multisig with the following signers:

Name	Address
Kiba Gateaux	meta-gov.eth
Leo	0x77aC1c732305bD1EbBe4FDfFa3f335344910bBBD
Clemens	0x9e67aDFFdfacA157efbC1F0A1785D4D873C20E22

Evaluation

The bio/acc cell will evaluate the amount of rewards based on the target metric of the milestone. So someone might do a pop-up city but if there are zero scientific experiments there then they get no bio/acc rewards. Or someone might have a huge launchpad raise of $5M so the bio/acc cell awards 5x the listed rate for a $1M raise.

The bio/acc incentives program metrics and payouts can be updated as necessary by the bio/acc cell and will have a formal re-approval every 6 months by BIO voters.

Distribution

132,800,000 BIO will be sent from the BIO protocol reserves to the bio/acc cell for the first generation bio/acc program. Retro-active rewards will be distributed immediately and be fully-vested.

Future bio/acc rewards will be distributed once approved by the bio/acc cell and have a 2-year linear vest. Further, rewards are distributed on a first-come-first-serve basis, meaning that once the 132,800,000 BIO rewards have been claimed, the program ends.

bioDAOs can work together to achieve bio/acc milestones e.g. product launches or popup cities. The involved bioDAOs must come to an agreement beforehand how bio/acc rewards will be distributed among themselves in agreement with the bio/acc cell before beginning work.

DeSci Data Room

We will be tracking metrics by building a “DeSci Data Room” that shows progress leading up to and after these bioDAOs reach these milestones. In addition to tracking individual bioDAOs’ progress, the data room will show metrics that represent the health of the ecosystem as a whole. The metrics we are tracking across the ecosystem are:

Here's the data formatted into a markdown table:

Target Goal	Metric
Research Funding Efficiency	$ of IPTs in treasury / $ of IPNFT grants
Intra-Ecosystem Liquidity	% of bioDAO liquidity in bioDAO/BIO pools
Inter-Ecosystem Liquidity	$ of BIO/ETH liquidity
Community Activity	# weekly active users on your discord server
Protocol Reserves Value	Value in ETH + USD
bioDAO Treasuries	Value in ETH + USD
POL Control	% of liquidity owned by bioDAOs vs BIO vs individuals